Chronic DiseaseNextcare_CCPNCT02956395
Implementation of Community-based Collaborative Management of Complex Chronic Patients
A study testing Integrated care intervention in people with Chronic Disease and Integrated Care, run by Hospital Clinic of Barcelona at 1 site in Spain.
Trial summary
Background/Aims: Large scale adoption of integrated care for chronic patients constitutes a key milestone to accelerate adaptation of current healthcare systems to the evolving needs triggered by population ageing and high prevalence of chronic conditions. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Chronic Disease, Integrated Care, Telemedicine
- What is being tested?
- Integrated care intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,000 participants
- Where
- 1 siteSpain
- Study dates
- 1 Feb 2018to 15 Jan 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Hospitalized patients and LACE index ≥7.
Who cannot join
- Severe psychiatric disorders
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Protocol for Regional Implementation of Community-based Collaborative Management of Complex Chronic Patients (CCP)
Background/Aims: Large scale adoption of integrated care for chronic patients constitutes a key milestone to accelerate adaptation of current healthcare systems to the evolving needs triggered by population ageing and high prevalence of chronic conditions. Lessons learnt from deployment experiences are being disseminated as "good practices". But, there is need for further assessment of implementation strategies in real world scenarios. Moreover, progresses achieved in disease-oriented integrated care cannot be automatically transferred to management of complex chronic patients (CCP). The protocol addresses five aims: 1) implementation of two integrated care interventions using a collaborative and adaptive case management (ACM) approach (i) Community-based management of CCP; and, ii) Integrated care for patients under long-term oxygen therapy (LTOT)); 2) adoption of information and communication technologies (ICT) required to support collaborative ACM; 3) to evaluate the impact of enhanced clinical health risk assessment and stratification; 5) to generate a roadmap for regional adoption of the CCP program.
Methods/Design: the CCP program will be deployed in three healthcare sector of Barcelona-Esquerra (AISBE) (520 k citizens) and in two other areas of Catalonia: Badalona Serveis Assistencials (BSA) (420 k citizens) and Lleida (366 k citizens) following Plan-Do-Study-Act iterative cycles, using the Model for Assessment of Telemedicine for evaluation purposes. The study also addresses the steps for scale-up of integrated care in the entire Catalan region (7.5 M citizens). Observational studies with matched controls have been planned for both Community-based management of CCP (n=3.000) and for Integrated care for patients under LTOT (n=500). Moreover, clustered randomized controlled trials (RCT) are planned on top of the observational studies to test specific questions (i.e. performance of the ICT platform providing ACM functionalities). Main components of CCP program are: a) patient stratification; b) comprehensive assessment strategies; c) ICT supported adaptive Case management; d) Roadmap for regional adoption.
Hypothesis: the CCP program will generate guidelines for large scale deployment of the CCP program, including transferability analysis, facilitating adoption of integrated care services for management of multi-morbidity.
Read the detailed description
Rationale \& hypothesis - Both, management of multi-morbidity and efficient collaboration between specialized care and community-based services are unmet needs that can be overcome by implementation of structured, but flexible, service workflows. That is, an ACM approach, as well as appropriate patient health risks assessment and stratification.
The service workflow has two sequential phases with specific target outcomes for each of them: i) Short-term (30 and 90 days after hospital discharge) prevention of hospital-related events after hospital discharge; and ii) Intervention aiming at long-term enhanced CCP management.
Objectives - To assess the impact of ICT-supported ACM on: i) reduction of early hospital-related events including hospital re-admissions, visits to emergency department and mortality; and, ii) Health value generation of the long-term intervention, defined as target outcomes achieved relative to their costs.Detailed outcomes include the eleven indicators recommended by the Spanish Health System covering the following dimensions: i) Characteristics of the study groups and health status (i.e, Users attended in primary care and, Health-related quality of life of patients and caregivers); ii) Intermediate outcomes (Emergency Department visits; General Practitioner visits; Cumulative days per year admitted in hospital; Poli-medication; Potentially avoidable hospitalizations; Hospital readmissions; Needs for social support); iii) Empowerment (Unhealthy life styles); and, iv) Structure (Access to ICT-supported integrated care). Moreover, through the program lifespan progresses consolidated by the International Consortium for Health Outcomes Measurement (ICHOM) will be incorporated.
Study design - The large-scale deployment will be evaluated as an observational study with a matched control group. Assessment will be done by an independent team. The number of patients to be included in the implementation study is approximately one-thousand individuals per year, including both conventional hospitalization and home hospitalization as recruitment sources.
Intervention - The general structure of the service workflow for the intervention group is as follows:
Case identification. Identification of candidates for inclusion into the program following the pre-defined inclusion/exclusion Case evaluation. During hospital admission or home hospitalization. A holistic characterization should be performed covering a threefold aim: i) Comprehensive assessment of each individual's need for health and social support; ii) Individualized pharmacological and non-pharmacological treatment, including adherence and self-management interventions needs; iii) Identification of short and long-term clinical requirements; and, iv) Assessment of barriers that may limit fulfilment of the program.
Personalized work plan definition - Personalized action plan based on case evaluation.
Work plan execution, follow-up and event handling with the support provided by information and communication technologies (ICT) that facilitate the program follow up and the handling of unexpected events by: i) fostering patient empowerment for self-management; ii) enhance patient adherence to the program; iii) facilitating remote supervision; and, iv) allowing patient monitoring.
Discharge - At the end of the program evaluation.Eventually, it can be moved to other types of integrated care services depending upon his/her needs.
The intervention is implemented by a multidisciplinary team from the hospital and from the Primary Care, of advanced-practice nurses, physicians, physiotherapists, community nurses, social workers having a general practitioner as a reference.
The collaboration between specialized care and primary care is guided by the reform of specialized care in the healthcare sectors initiated in 2006. Both teams share ICT-supported tools.
The intervention during hospital admission includes four key features: 1) A comprehensive assessment of the patient at entry; 2) A two-hour educational program administered at entry by a nurse followed by distribution of patient-specific support material.
Intervention after hospital discharge a) Phone call at 24 hours; b) Home visit at 72 hours after discharge. Accessibility to the point of care available 24 hours/day; PHF, as self-management tool and appointment at 1m after discharge.
After the transitional phase, the advanced-practice nurses perform regular training sessions to the community-based care teams, facilitate high accessibility to specialized care as needed and support functionalities of the PHF for the patients admitted into the program.
The number of home care visits, as well as access to specialized care, during the follow-up 12 month period is individually tailored, and dynamically adapted, to patient needs. Moreover, planned visits by specialized professionals can be scheduled through the day hospital or home visits if this was deemed necessary by primary care teams.
ICT- Support - The three main actors, namely: i) the healthcare professionals with access to an adaptive case management system for work plan prescription, follow-up, coaching, and care-coordination across healthcare tiers; ii) the adaptive case management system supporting execution of the patient work plan and providing a bridge of interoperability and collaborative tools among the patient (through the PHF), the case manager and the electronic medical record; and, iii) the patient, with access to the PHF wherein she/he can answer questionnaires, perform monitoring through mHealth apps, and have access to a follow-up reports and tailored educational information.
Control group - Patients assigned to usual care will follow conventional treatment, being managed by their physician without support by the multidisciplinary team, as described above for the intervention group.
Clinical assessment - Evaluation will be done by an independent team at baseline and after the 12-month follow-up. The questionnaires are those used by the integrated care team with additions designed to capture patient empowerment characteristics: mental status, activities of daily living, anxiety and depression, health-related quality of life; acute episodes requiring emergency department consultations and/or hospital admissions within the healthcare sector will be assessed using shared registries from the public health system. Moreover, core outcomes, will be assessed from public registries.
Data analysis- A sample size of 200 patients per group was necessary to recognize statistically significant effects of the intervention. The estimated number of patients identified during the screening process (one-thousand per year) is markedly higher than minimum required, thus ensuring enough statistical power.
Results will be expressed as mean and standard deviation (SD), or as number and percentages, in the corresponding categories. Comparisons between the two study groups on admission and at 12 months will be performed using unpaired Student t-test for continuous variables, if variables to be compared have two categories; and, chi-square tests for non-continuous variables. Changes within each group were assessed by paired analysis (for example using paired t test). The effects of the intervention on mortality and time to admission will be analyzed respectively using multivariate logistic and Cox regression models, adjusted for baseline differences between groups. We will build saturated models introducing all of the covariates which result statistically significant during bivariate assessment. After this, we will build parsimonious models by excluding, one to one, all of the variables not significant according to the Wald test p-value. Finally, we will decide the final model, comparing the saturated with the parsimonious models, according to the likelihood ratio test.Statistical significance is set at a p value less than 0.05. Analyses will be done with SPSS release 20.
Additionally, qualitative assessment of technology will be done using standard questionnaires and through focus groups.
- Conditions
- Chronic Disease, Integrated Care, Telemedicine
- Being tested
- Integrated care intervention
- Keywords
- adaptive case management approach, Transitional Care, multimorbidity
- Medical subject headings
- Chronic Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Integrated care interventionOther
Integrated care intervention is implemented by a multidisciplinary team from the hospital and from the Primary Care.
The intervention after hospital discharge a) Phone call at 24 hours; b) Home visit at 72 hours after discharge by one member of the transitional care team, if is needed; During this visit, the therapeutic plan for each patient will be customized to their individual frailty factors and shared with the primary care team. Reinforcement of the logistics for treatment of co-morbidities and social support will be done accordingly; c) Accessibility to the point of care available 24 hours/day ; d) Accessibility to the individualized PHF, as self-management tool ; d) appointment at 1m after discharge and after 12 m
| Study group | Role | What they receive |
|---|---|---|
| Integrated care group | Active comparator | Integrated care intervention is implemented by a multidisciplinary team from the hospital and from the Primary Care in three healthcare sectors: Barcelona-Esquerra, Lleida and Badalona. Receives: Other: Integrated care intervention |
| Conventional care group | No intervention | Patients assigned to the control group will be from other healthcare sectors in Catalonia with similar characteristics. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction of early hospital-related events after hospital discharge
Hospital re-admissions
Measured: 30 and 90 days and 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Nov 2016 (estimated)
- Study start1 Feb 2018
- Primary completion1 Sep 2019
- Study completion15 Jan 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Chronic DiseaseStudies of the same condition, open and under way.
- More trials run by Hospital Clinic of BarcelonaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 3,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital Clinic of Barcelona
- Sponsor type
- University, hospital or other
- Collaborators
- Badalona Serveis Assistencials, Institut de Recerca Biomèdica de Lleida
- Responsible party
- Principal investigator, Carme Hernandez, Hospital Clinic of Barcelona
- Investigators
- Carme Hernandez, RN, Principal investigator, Hospital Clinic of Barcelona
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02956395
- Sponsor's protocol ID
- Nextcare_CCP
- Acronym
- Nextcare_CCP
- Status last verified
- Jun 2020
- First submitted
- 2 Nov 2016
- Last updated
- 16 Jun 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Vela E, Tenyi A, Cano I, Monterde D, Cleries M, Garcia-Altes A, Hernandez C, Escarrabill J, Roca J. Population-based analysis of patients with COPD in Catalonia: a cohort study with implications for clinical management. BMJ Open. 2018 Mar 6;8(3):e017283. doi: 10.1136/bmjopen-2017-017283.
PubMed 29511004
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Protocol for Regional Implementation of Community-based Collaborative Management of Complex Chronic Patients (CCP)
- ClinicalTrials.gov ID
- NCT02956395
- Acronym / sponsor ID
- Nextcare_CCP / Nextcare_CCP
- Conditions
- Chronic Disease, Integrated Care, Telemedicine
- Keywords
- adaptive case management approach, Transitional Care, multimorbidity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 3,000 participants (actual)
- Lead sponsor
- Hospital Clinic of BarcelonaUniversity, hospital or other
- Collaborators
- Badalona Serveis Assistencials, Institut de Recerca Biomèdica de Lleida
- Study start
- 1 Feb 2018 (actual)
- Primary completion
- 1 Sep 2019 (actual)
- Study completion
- 15 Jan 2020 (actual)
- First posted
- 7 Nov 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background/Aims: Large scale adoption of integrated care for chronic patients constitutes a key milestone to accelerate adaptation of current healthcare systems to the evolving needs triggered by population ageing and high prevalence of chronic conditions. Lessons learnt from deployment experiences are being disseminated as "good practices". But, there is need for further assessment of implementation strategies in real world scenarios. Moreover, progresses achieved in disease-oriented integrated care cannot be automatically transferred to management of complex chronic patients (CCP). The protocol addresses five aims: 1) implementation of two integrated care interventions using a collaborative and adaptive case management (ACM) approach (i) Community-based management of CCP; and, ii) Integrated care for patients under long-term oxygen therapy (LTOT)); 2) adoption of information and communication technologies (ICT) required to support collaborative ACM; 3) to evaluate the impact of enhanced clinical health risk assessment and stratification; 5) to generate a roadmap for regional adoption of the CCP program.
Methods/Design: the CCP program will be deployed in three healthcare sector of Barcelona-Esquerra (AISBE) (520 k citizens) and in two other areas of Catalonia: Badalona Serveis Assistencials (BSA) (420 k citizens) and Lleida (366 k citizens) following Plan-Do-Study-Act iterative cycles, using the Model for Assessment of Telemedicine for evaluation purposes. The study also addresses the steps for scale-up of integrated care in the entire Catalan region (7.5 M citizens). Observational studies with matched controls have been planned for both Community-based management of CCP (n=3.000) and for Integrated care for patients under LTOT (n=500). Moreover, clustered randomized controlled trials (RCT) are planned on top of the observational studies to test specific questions (i.e. performance of the ICT platform providing ACM functionalities). Main components of CCP program are: a) patient stratification; b) comprehensive assessment strategies; c) ICT supported adaptive Case management; d) Roadmap for regional adoption.
Hypothesis: the CCP program will generate guidelines for large scale deployment of the CCP program, including transferability analysis, facilitating adoption of integrated care services for management of multi-morbidity.
Detailed description
Rationale \& hypothesis - Both, management of multi-morbidity and efficient collaboration between specialized care and community-based services are unmet needs that can be overcome by implementation of structured, but flexible, service workflows. That is, an ACM approach, as well as appropriate patient health risks assessment and stratification.
The service workflow has two sequential phases with specific target outcomes for each of them: i) Short-term (30 and 90 days after hospital discharge) prevention of hospital-related events after hospital discharge; and ii) Intervention aiming at long-term enhanced CCP management.
Objectives - To assess the impact of ICT-supported ACM on: i) reduction of early hospital-related events including hospital re-admissions, visits to emergency department and mortality; and, ii) Health value generation of the long-term intervention, defined as target outcomes achieved relative to their costs.Detailed outcomes include the eleven indicators recommended by the Spanish Health System covering the following dimensions: i) Characteristics of the study groups and health status (i.e, Users attended in primary care and, Health-related quality of life of patients and caregivers); ii) Intermediate outcomes (Emergency Department visits; General Practitioner visits; Cumulative days per year admitted in hospital; Poli-medication; Potentially avoidable hospitalizations; Hospital readmissions; Needs for social support); iii) Empowerment (Unhealthy life styles); and, iv) Structure (Access to ICT-supported integrated care). Moreover, through the program lifespan progresses consolidated by the International Consortium for Health Outcomes Measurement (ICHOM) will be incorporated.
Study design - The large-scale deployment will be evaluated as an observational study with a matched control group. Assessment will be done by an independent team. The number of patients to be included in the implementation study is approximately one-thousand individuals per year, including both conventional hospitalization and home hospitalization as recruitment sources.
Intervention - The general structure of the service workflow for the intervention group is as follows:
Case identification. Identification of candidates for inclusion into the program following the pre-defined inclusion/exclusion Case evaluation. During hospital admission or home hospitalization. A holistic characterization should be performed covering a threefold aim: i) Comprehensive assessment of each individual's need for health and social support; ii) Individualized pharmacological and non-pharmacological treatment, including adherence and self-management interventions needs; iii) Identification of short and long-term clinical requirements; and, iv) Assessment of barriers that may limit fulfilment of the program.
Personalized work plan definition - Personalized action plan based on case evaluation.
Work plan execution, follow-up and event handling with the support provided by information and communication technologies (ICT) that facilitate the program follow up and the handling of unexpected events by: i) fostering patient empowerment for self-management; ii) enhance patient adherence to the program; iii) facilitating remote supervision; and, iv) allowing patient monitoring.
Discharge - At the end of the program evaluation.Eventually, it can be moved to other types of integrated care services depending upon his/her needs.
The intervention is implemented by a multidisciplinary team from the hospital and from the Primary Care, of advanced-practice nurses, physicians, physiotherapists, community nurses, social workers having a general practitioner as a reference.
The collaboration between specialized care and primary care is guided by the reform of specialized care in the healthcare sectors initiated in 2006. Both teams share ICT-supported tools.
The intervention during hospital admission includes four key features: 1) A comprehensive assessment of the patient at entry; 2) A two-hour educational program administered at entry by a nurse followed by distribution of patient-specific support material.
Intervention after hospital discharge a) Phone call at 24 hours; b) Home visit at 72 hours after discharge. Accessibility to the point of care available 24 hours/day; PHF, as self-management tool and appointment at 1m after discharge.
After the transitional phase, the advanced-practice nurses perform regular training sessions to the community-based care teams, facilitate high accessibility to specialized care as needed and support functionalities of the PHF for the patients admitted into the program.
The number of home care visits, as well as access to specialized care, during the follow-up 12 month period is individually tailored, and dynamically adapted, to patient needs. Moreover, planned visits by specialized professionals can be scheduled through the day hospital or home visits if this was deemed necessary by primary care teams.
ICT- Support - The three main actors, namely: i) the healthcare professionals with access to an adaptive case management system for work plan prescription, follow-up, coaching, and care-coordination across healthcare tiers; ii) the adaptive case management system supporting execution of the patient work plan and providing a bridge of interoperability and collaborative tools among the patient (through the PHF), the case manager and the electronic medical record; and, iii) the patient, with access to the PHF wherein she/he can answer questionnaires, perform monitoring through mHealth apps, and have access to a follow-up reports and tailored educational information.
Control group - Patients assigned to usual care will follow conventional treatment, being managed by their physician without support by the multidisciplinary team, as described above for the intervention group.
Clinical assessment - Evaluation will be done by an independent team at baseline and after the 12-month follow-up. The questionnaires are those used by the integrated care team with additions designed to capture patient empowerment characteristics: mental status, activities of daily living, anxiety and depression, health-related quality of life; acute episodes requiring emergency department consultations and/or hospital admissions within the healthcare sector will be assessed using shared registries from the public health system. Moreover, core outcomes, will be assessed from public registries.
Data analysis- A sample size of 200 patients per group was necessary to recognize statistically significant effects of the intervention. The estimated number of patients identified during the screening process (one-thousand per year) is markedly higher than minimum required, thus ensuring enough statistical power.
Results will be expressed as mean and standard deviation (SD), or as number and percentages, in the corresponding categories. Comparisons between the two study groups on admission and at 12 months will be performed using unpaired Student t-test for continuous variables, if variables to be compared have two categories; and, chi-square tests for non-continuous variables. Changes within each group were assessed by paired analysis (for example using paired t test). The effects of the intervention on mortality and time to admission will be analyzed respectively using multivariate logistic and Cox regression models, adjusted for baseline differences between groups. We will build saturated models introducing all of the covariates which result statistically significant during bivariate assessment. After this, we will build parsimonious models by excluding, one to one, all of the variables not significant according to the Wald test p-value. Finally, we will decide the final model, comparing the saturated with the parsimonious models, according to the likelihood ratio test.Statistical significance is set at a p value less than 0.05. Analyses will be done with SPSS release 20.
Additionally, qualitative assessment of technology will be done using standard questionnaires and through focus groups.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Integrated care group | Active comparator | Other: Integrated care interventionIntegrated care intervention is implemented by a multidisciplinary team from the hospital and from the Primary Care in three healthcare sectors: Barcelona-Esquerra, Lleida and Badalona. |
| Conventional care group | No intervention | –Patients assigned to the control group will be from other healthcare sectors in Catalonia with similar characteristics. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Hospitalized patients and LACE index ≥7.
Key exclusion criteria (1 listed)
- Severe psychiatric disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Integrated care interventionIntegrated care intervention is implemented by a multidisciplinary team from the hospital and from the Primary Care. The intervention after hospital discharge a) Phone call at 24 hours; b) Home visit at 72 hours after discharge by one member of the transitional care team, if is needed; During this visit, the therapeutic plan for each patient will be customized to their individual frailty factors and shared with the primary care team. Reinforcement of the logistics for treatment of co-morbidities and social support will be done accordingly; c) Accessibility to the point of care available 24 hours/day ; d) Accessibility to the individualized PHF, as self-management tool ; d) appointment at 1m after discharge and after 12 m | Other | Integrated care group |
Primary outcome
Reduction of early hospital-related events after hospital discharge
Time frame: 30 and 90 days and 12 months
Hospital re-admissions
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2020.
- Derived from this study: PubMed 29511004Vela E, Tenyi A, Cano I, Monterde D, Cleries M, Garcia-Altes A, Hernandez C, Escarrabill J, Roca J. Population-based analysis of patients with COPD in Catalonia: a cohort study with implications for clinical management. BMJ Open. 2018 Mar 6;8(3):e017283. doi: 10.1136/bmjopen-2017-017283.
- Individual participant dataSharing planned: Undecided
Related trials for Chronic Disease
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carme Hernandez, RN principal investigator
Hospital Clinic of Barcelona
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Integrated care intervention in people with Chronic Disease and Integrated Care, run by Hospital Clinic of Barcelona at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction of early hospital-related events after hospital discharge (time frame: 30 and 90 days and 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02956395, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2020.